Johnson & Johnson (JNJ) : Nations Financial Group Inc Ia Adv scooped up 954 additional shares in Johnson & Johnson during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 10,402 shares of Johnson & Johnson which is valued at $1,281,734.Johnson & Johnson makes up approximately 1.31% of Nations Financial Group Inc Ia Adv’s portfolio.
Other Hedge Funds, Including , Texas Yale Capital Corp. reduced its stake in JNJ by selling 87 shares or 0.21% in the most recent quarter. The Hedge Fund company now holds 42,009 shares of JNJ which is valued at $5,176,349. Johnson & Johnson makes up approx 0.49% of Texas Yale Capital Corp.’s portfolio.Public Sector Pension Investment Board boosted its stake in JNJ in the latest quarter, The investment management firm added 74,600 additional shares and now holds a total of 521,370 shares of Johnson & Johnson which is valued at $64,243,211. Johnson & Johnson makes up approx 0.77% of Public Sector Pension Investment Board’s portfolio.Weik Investment Services Inc reduced its stake in JNJ by selling 717 shares or 1.73% in the most recent quarter. The Hedge Fund company now holds 40,624 shares of JNJ which is valued at $5,005,689. Johnson & Johnson makes up approx 2.87% of Weik Investment Services Inc’s portfolio.Ssi Investment Management Inc boosted its stake in JNJ in the latest quarter, The investment management firm added 157 additional shares and now holds a total of 8,214 shares of Johnson & Johnson which is valued at $1,016,647. Johnson & Johnson makes up approx 0.28% of Ssi Investment Management Inc’s portfolio.Becker Capital Management Inc reduced its stake in JNJ by selling 105,888 shares or 21.44% in the most recent quarter. The Hedge Fund company now holds 388,065 shares of JNJ which is valued at $48,081,254. Johnson & Johnson makes up approx 1.89% of Becker Capital Management Inc’s portfolio.
Johnson & Johnson opened for trading at $119.3 and hit $120.13 on the upside on Monday, eventually ending the session at $119.92, with a gain of 0.74% or 0.88 points. The heightened volatility saw the trading volume jump to 50,74,924 shares. Company has a market cap of $328,086 M.
On the company’s financial health, Johnson & Johnson reported $1.74 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 19, 2016. Analyst had a consensus of $1.68. The company had revenue of $18482.00 million for the quarter, compared to analysts expectations of $17985.80 million. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.71 EPS.
Many Wall Street Analysts have commented on Johnson & Johnson. Company shares were Reiterated by UBS on Jul 20, 2016 to “Buy”, Firm has raised the Price Target to $ 137 from a previous price target of $126 .Company shares were Reiterated by RBC Capital Mkts on Jul 20, 2016 to “Outperform”, Firm has raised the Price Target to $ 133 from a previous price target of $125 .Standpoint Research Initiated Johnson & Johnson on May 20, 2016 to “Sell”, Price Target of the shares are set at $94.
Johnson & Johnson is a holding company. The Company is engaged in the research and development manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer Pharmaceutical and Medical Devices. The Company’s subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States Belgium Brazil Canada China France Germany India Israel Japan the Netherlands Singapore Switzerland and the United Kingdom.